Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES Steering Committee and Investigators.

N Engl J Med. 2016 Jul 7;375(1):35-43. doi: 10.1056/NEJMoa1603060. Epub 2016 May 10.

2.

Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort study.

Petrovičová A, Kurča E, Brozman M, Hasilla J, Vahala P, Blaško P, Andrášová A, Hatala R, Urban L, Sivák Š.

BMC Cardiovasc Disord. 2015 Dec 3;15:160. doi: 10.1186/s12872-015-0160-8.

3.

Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.

Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Gdovinova Z, Švigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Bašic-Kes V, Vilionskis A, Jatuzis D, Krespi Y, Shamalov N, Andonova S, Ahmed N, Wahlgren N; Safe Implementation of Treatments in Stroke–East Registry (SITS-EAST) Investigators.

Stroke. 2015 Nov;46(11):3184-9. doi: 10.1161/STROKEAHA.115.010420. Epub 2015 Oct 8.

PMID:
26451024
4.

Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.

Tsivgoulis G, Kadlecová P, Kobayashi A, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Katsanos AH, Rudolf J, Krespi Y, Mikulik R.

Stroke. 2015 Sep;46(9):2681-4. doi: 10.1161/STROKEAHA.115.010244. Epub 2015 Jul 14.

5.

Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtype.

Novotná J, Kadlecová P, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Kõrv J, Demarin V, Vilionskis A, Mikulík R; SITS-EAST Investigators.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2533-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.034. Epub 2014 Sep 27.

PMID:
25267589
6.

Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke.

Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Svigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N, Wahlgren N; Safe Implementation of Treatments in Stroke–Eastern Europe (SITS-EAST) Investigators.

Stroke. 2014 Mar;45(3):770-5. doi: 10.1161/STROKEAHA.113.003744. Epub 2014 Feb 4.

7.

Benefit of thrombolysis for stroke is maintained around the clock: results from the SITS-EAST Registry.

Kõrv J, Vibo R, Kadlecová P, Kobayashi A, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Fekete K, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N, Mikulík R; Safe Implementation of Treatments in Stroke - East Registry Investigators.

Eur J Neurol. 2014;21(1):112-7. doi: 10.1111/ene.12257. Epub 2013 Sep 16.

PMID:
24102712
8.

Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.

Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charissé G, Fiebach JB, Schwab S, Schäbitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Köhrmann M, Berrouschot J; AXIS 2 Investigators.

Stroke. 2013 Oct;44(10):2681-7. doi: 10.1161/STROKEAHA.113.001531. Epub 2013 Aug 20.

9.

Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.

Lees KR, Bornstein N, Diener HC, Gorelick PB, Rosenberg G, Shuaib A; MACSI Investigators.

Stroke. 2013 Mar;44(3):580-4. doi: 10.1161/STROKEAHA.111.000013. Epub 2013 Feb 7. Erratum in: Stroke. 2013 Mar;44(3) :e23.

10.

Factors influencing in-hospital delay in treatment with intravenous thrombolysis.

Mikulík R, Kadlecová P, Czlonkowska A, Kobayashi A, Brozman M, Svigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N; Safe Implementation of Treatments in Stroke-East Registry (SITS-EAST) Investigators.

Stroke. 2012 Jun;43(6):1578-83. doi: 10.1161/STROKEAHA.111.644120. Epub 2012 Mar 15.

11.

Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.

Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N; SITS investigators.

Neurology. 2012 Mar 20;78(12):880-7. doi: 10.1212/WNL.0b013e31824d966b. Epub 2012 Mar 7.

PMID:
22402853
12.

Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe.

Karlinski M, Kobayashi A, Mikulik R, Sanak D, Wahlgren N, Czlonkowska A; SITS-EAST Collaborative Group.

Int J Stroke. 2012 Dec;7(8):615-22. doi: 10.1111/j.1747-4949.2011.00733.x. Epub 2012 Feb 7.

PMID:
22309238
13.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.

Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Erratum in: Lancet. 2011 Jul 30;378(9789):402.

PMID:
21616527
14.

Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg?

Diedler J, Ahmed N, Glahn J, Grond M, Lorenzano S, Brozman M, Sykora M, Ringleb P.

Stroke. 2011 Jun;42(6):1615-20. doi: 10.1161/STROKEAHA.110.603514. Epub 2011 Apr 14.

15.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G.

Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.

PMID:
20472172
16.
17.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

18.

[Quadruparesis as a complication of acute pancreatitis--case report].

Bircak J, Bakos E, Dubaj M, Strmen J, Brozman M.

Rozhl Chir. 2007 Jul;86(7):343-5. Slovak.

PMID:
17879709
19.

NXY-059 for acute ischemic stroke.

Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators.

N Engl J Med. 2006 Feb 9;354(6):588-600.

20.

Separation of Siamese twins in Bratislava.

Siman J, Payer J, Brozman M, Tanuska D, Pevalová L, Macek M, Babala J, Jursova M, Cingel V, Duchaj B.

Bratisl Lek Listy. 2004;105(2):37-44.

PMID:
15253533
Items per page

Supplemental Content

Loading ...
Write to the Help Desk